CRISPR–Cas12-based detection of SARS-CoV-2
Mammoth Biosciences (United States) · University of California, San Francisco · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,767
total citations
- FWCI
- 166.12
- Percentile
- 100%
- References
- 28
Citations per year
Authors
20- JPJames P. BroughtonCorresponding
Mammoth Biosciences (United States)
- XDXianding Deng
University of California, San Francisco, Global Viral, Abbott (United States)
- GYGuixia Yu
University of California, San Francisco, Global Viral, Abbott (United States)
- CLClare L. Fasching
Mammoth Biosciences (United States)
- VSVenice Servellita
University of California, San Francisco, Global Viral, Abbott (United States)
Topics & keywords
Topics
Keywords
- Outbreak
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Virology
- Coronavirus disease 2019 (COVID-19)
- CRISPR
- Betacoronavirus
- Pandemic
- 2019-20 coronavirus outbreak
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- DODivision of Intramural Research, National Institute of Allergy and Infectious DiseasesAward: R33-AI129455
- CACharles and Helen Schwab Foundation
- NINational Institutes of HealthAwards: R33-AI129455, R01-HL105704
- NHNational Heart, Lung, and Blood InstituteAward: R01-HL105704
- NINational Institute of Allergy and Infectious DiseasesAward: R33-AI129455